Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Funding Announcements

Apply for Grants

The Division of Cancer Treatment and Diagnosis (DCTD) funds a large portfolio of grants and contracts. The table below contains DCTD's current Notices of Funding Opportunities (NOFOs).

Please visit this page regularly for updates.

Funding Opportunities Supported by DCTD Programs

TitleAnnouncement NumberExpiration DateActivity CodeProgram/Contact
Bioengineering Research Grants (Clinical Trial Optional)PAR-25-458September 8, 2025R01CDP/Miguel Ossandon
Coinfection and Cancer (Clinical Trial Not Allowed)PAR-25-083January 8, 2026R21CIP/Pushpa Tandon
Innovative Research in Cancer Nanotechnology (IRCN; Clinical Trial Not Allowed)PAR-25-106May 5, 2026R01CIP NANO/Piotr Grodzinski and Leela Rani Avula
Assay Development and Screening for Discovery of Chemical Probes, Drugs or Immunomodulators (Clinical Trial Not Allowed)PAR-25-153September 8, 2026R01DTP/Suzanne Forry and Connie Sommers
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026PAR-23-284September 26, 2026P50TRP Staff
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (Clinical Trial Not Allowed)PAR-24-304October 15, 2026R01CDP/Sumana Dey
Assay Validation of High Quality Markers for Clinical Studies in Cancer (Clinical Trial Not Allowed)PAR-25-074October 15, 2026UH2/UH3CDP/Sumana Dey, CTEP/Minyung Song
Assay Validation of High Quality Markers for Clinical Studies in Cancer (Clinical Trial Not Allowed)PAR-25-075October 15, 2026UH2/UH3CDP/Sumana Dey, CTEP/Minyung Song
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (Clinical Trials Optional)PAR-25-079January 8, 2027R01CIP/Darrell Tata
NCI's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (Clinical Trial Required)PAR-25-081January 8, 2027R01CTEP/Lori A. Henderson, CIP/Lalitha Shankar, RRP/Jeff Buchsbaum, CDP/Magdalena Thurin, OCCAM/Dan Xi
Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical ApplicationsNOT-EB-23-022January 27, 2027NOSIRRP/Jeff Buchsbaum
Research Projects to Develop Oncoaging Models for Cancer ResearchNOT-CA-23-092July 31, 2027NOSIDTP/Weiwei Chen
Bioengineering Partnerships with Industry (Clinical Trial Optional)PAR-24-325September 8, 2027U01CDP/Miguel Ossandon
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)PAR-25-336November 16, 2027 R01CIP NANO/Piotr Grodzinski and Yicong Wu
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (Clinical Trial Optional)
 		PAR-25-175January 8, 2028R01CIP/Yisong Wang
Molecular Imaging of Inflammation in Cancer (Clinical Trial Not Allowed)PAR-24-311January 8, 2028R01CIP/Charles Lin

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Funding Announcements was originally published by the National Cancer Institute.”

Email